医学
心脏病学
内科学
脑梗塞
冲程(发动机)
磁共振成像
放射科
梗塞
缺血性中风
中枢神经系统疾病
脑梗塞
临床神经学
缺血
脑血管循环
作者
Tengfei Yu,Tze Kin Lau,Yanan Liu,Runting Li,Fa Lin,Zhenshan Song,Qinghui Zhu,Yú Chen,Tianxin Li,Jing Jing,Xiaolin Chen
出处
期刊:Stroke
[Lippincott Williams & Wilkins]
日期:2025-12-11
卷期号:57 (3): 721-731
被引量:1
标识
DOI:10.1161/strokeaha.125.052474
摘要
BACKGROUND: Aneurysmal subarachnoid hemorrhage (aSAH) is an acute cerebrovascular disease. The concept of ultraearly infarction is gaining recognition. The advent of low-field portable magnetic resonance imaging (LF-pMRI) technology offers a promising new avenue for exploration. We aimed to identify the developmental pattern of ultraearly infarction after aSAH with LF-pMRI. METHODS: This was a prospective, observational, single-center cohort study. Data for patients with consecutive subarachnoid hemorrhage admitted to Beijing Tiantan Hospital from January 1, 2024 to July 31, 2024 were obtained. The inclusion criteria were as follows: (1) diagnosis as subarachnoid hemorrhage, (2) patients who underwent computed tomography, computed tomography angiography, and LF-pMRI in the emergency room before treatment of the aneurysm. Patients with comorbidities, angiographically negative subarachnoid hemorrhage, onset time >72 hours, and Hunt-Hess scale score of 5 were excluded. All enrolled patients underwent LF-pMRI on admission to evaluate the occurrence of ultraearly infarction. Primary outcome was the occurrence of unfavorable functional outcomes (modified Rankin Scale score ≥2). Modified Rankin Scale score was identified by physicians at discharge. Patients who received emergency aneurysm treatment and received complete LF-pMRI process during hospitalization were further evaluated for the risk of delayed cerebral infarction (DCI), which was the secondary outcome. RESULTS: =0.032) were independent risk factors. CONCLUSIONS: LF-pMRI can be utilized to detect the occurrence of ultraearly cerebral infarction in patients with aSAH. Those patients with aSAH who experience ultraearly cerebral infarction have a higher risk of DCI and a greater incidence of unfavorable functional outcomes. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT04785976.
科研通智能强力驱动
Strongly Powered by AbleSci AI